Statins: optimising therapy
How do we optimise a patient’s statin therapy for the management of dyslipidaemia with minimal side effects?
Depression: supporting quality use of antidepressants
Review your quality use of antidepressants with patients with depression.
Peptic ulcer disease and non-steroidal anti-inflammatory drugs
Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used medicines. They are associated with gastrointestinal mucosal injury.
Real-time prescription monitoring (SafeScript)
A series of three modules to train prescribers and pharmacists on the use of the SafeScript system.
Access is restricted to health practitioners in Victoria.
Chronic heart failure
The clinical diagnosis of heart failure should be confirmed by echocardiogram to determine the underlying mechanism and to measure the left ventricular ejection fraction.
‘Cephalosporin allergy’ label is misleading
Penicillins and cephalosporins can cause a similar spectrum of allergic reactions at a similar rate.
Long-term prescribing of new oral anticoagulants
Warfarin and the new oral anticoagulants are licensed for non-valvular atrial fibrillation and venous thromboembolism. The choice of anticoagulant depends on the characteristics of the patient and the medicine.
COPD: navigating inhaled medicines management
There are more than a dozen different inhaled medicines for chronic obstructive pulmonary disease (COPD) and multiple devices. How can you help your patients get the best out of theirs?
The management of gastro-oesophageal reflux disease
If there are no features of serious disease, suspected gastro-oesophageal reflux disease can be initially managed with a trial of a proton pump inhibitor for 4–8 weeks. This should be taken 30–60 minutes before food for optimal effect.
Charlotte Keung and Geoffrey Hebbard, Aust Prescr 2016:39:6-10